Bilypsa Tablet 4 mg (Saroglitazar)

Last Updated on 08/13/2026 ✔ Medically Reviewed by Dr. Arjun Srivastav

What Is Bilypsa Tablet?

Bilypsa Tablet is an oral medicine containing saroglitazar 4 mg, which belongs to a group of medicines called PPAR agonists. It has effects on both fat and glucose metabolism, making it useful in the management of diabetic dyslipidemia, a condition in which people with diabetes have unhealthy levels of triglycerides and other blood lipids.

Unlike medicines that focus mainly on blood glucose, saroglitazar also acts on lipid metabolism. Its activity on PPAR-α and PPAR-γ pathways can help improve the way the body handles fats and responds to insulin. For this reason, Bilypsa tablet may be prescribed when abnormal lipid levels occur alongside type 2 diabetes, depending on the individual’s condition and existing treatment.

Saroglitazar has also been investigated for metabolic liver conditions such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). These conditions are commonly associated with problems such as obesity, insulin resistance, type 2 diabetes and abnormal cholesterol or triglyceride levels. Research into saroglitazar has looked at whether its effects on lipid metabolism and insulin sensitivity may also benefit people with these liver conditions.

Uses of Bilypsa 4 mg Tablet

Bilypsa 4 mg is mainly prescribed for people with type 2 diabetes who also have problems with triglycerides or other blood fats. Saroglitazar works on pathways involved in fat and glucose metabolism, so it may be used when managing these conditions together.

Diabetic Dyslipidemia

This medication may be prescribed for diabetic dyslipidemia, where diabetes is accompanied by raised triglycerides and changes in cholesterol levels. It can be used as part of a wider treatment plan when diet, exercise and other medicines have not provided sufficient control.

High Triglycerides

Triglycerides are fats carried in the bloodstream. Persistently high levels can occur alongside type 2 diabetes and other metabolic problems. Saroglitazar helps regulate fat metabolism and may lower triglyceride levels when used as directed by a healthcare professional.

Type 2 Diabetes With Changes in Blood Fats

People with type 2 diabetes may have a combination of raised triglycerides, cholesterol changes and reduced insulin sensitivity. Bilypsa tablet can be prescribed as an additional treatment when these problems occur together. It does not replace the usual measures used to manage diabetes, such as a suitable diet, physical activity and other prescribed medicines.

Bilypsa 4 mg Tablet Uses in Fatty Liver

Saroglitazar has also been studied in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), conditions in which excess fat can build up in the liver and, in some people, cause inflammation or liver injury. Research has examined whether saroglitazar’s effects on fat metabolism and insulin sensitivity may help people with these metabolic liver conditions.

How Does Bilypsa 4 mg Work?

This medicine contains saroglitazar, which works through two receptors called PPAR-α and PPAR-γ. Its actions can be understood simply as follows:

• Acts on PPAR-α: Helps the body manage fatty acids and triglycerides, which can reduce the amount of circulating triglycerides.
• Acts on PPAR-γ: Supports insulin sensitivity and helps regulate the way the body handles glucose and fats.
• Supports fat metabolism: By acting on these pathways, saroglitazar can improve the processing of fats in the body.
• May benefit metabolic liver conditions: Its effects on fat metabolism and insulin sensitivity are why saroglitazar has also been studied in conditions such as fatty liver associated with metabolic dysfunction.
• Works as part of an overall treatment plan: This drug is generally used alongside appropriate diet, physical activity and other treatments when prescribed.

The exact response can vary between individuals, so the medicine should be taken according to the healthcare professional’s instructions rather than changing the dose independently.

Bilypsa 4 mg Dosage

Bilypsa tablet is available as a 4 mg tablet of saroglitazar. The dose and length of treatment are decided by the prescribing doctor based on the person’s condition, other medicines, and response to treatment.

• Take the medicine exactly as prescribed.
• Do not take more tablets than recommended, even if you feel that your symptoms have not improved.
• Try to take it at the same time each day to maintain a regular routine.
• Do not stop treatment suddenly without discussing it with your doctor.
• Your doctor may review your blood tests and overall response during treatment.

How to Take Bilypsa Tablet

• Swallow the tablet with water.
• Take it according to the instructions on your prescription.
• Do not crush or chew the tablet unless your doctor or pharmacist specifically tells you to do so.
• If you are taking other medicines for diabetes or high cholesterol, follow the schedule provided by your healthcare professional.

Missed Dose

If you forget a dose, take it when you remember unless it is nearly time for your next one. In that case, skip the missed tablet and continue with your usual schedule. Do not take two doses together to make up for the missed one.

Overdose

Taking more Bilypsa tablets than prescribed can increase the risk of unwanted effects. If you have accidentally taken an excessive amount, seek medical advice promptly and tell the healthcare professional how much you took.

Bilypsa Tablet Side Effects

Like any medicine, Bilypsa may cause unwanted effects, although they do not occur in everyone. The type and severity can vary between individuals.

This medication can be taken alongside other medicines in some patients, but the full medication list should be reviewed by a healthcare professional before treatment. This includes prescription medicines, over-the-counter products, and supplements.

Safety Warnings While Taking Bilypsa Tablet

Before starting Bilypsa, tell your doctor about your medical history and any medicines or supplements you use. Certain health conditions may require closer monitoring during treatment.

Heart conditions

Tell your doctor about any existing heart problems and report new chest discomfort, breathing difficulty, swelling or unusual weakness.

Liver and kidney health

Inform your doctor about liver or kidney problems, as your medical history may affect how your treatment is monitored.

Pregnancy and breastfeeding

Tell your doctor if you are pregnant, planning pregnancy or breastfeeding before using Bilypsa.

Children

Keep Bilypsa away from children and use it in younger patients only when specifically prescribed by a healthcare professional.

Alcohol and food

Discuss alcohol use with your doctor and follow the prescribed instructions about taking Bilypsa with meals.

Allergies

Avoid Bilypsa if you have previously reacted to saroglitazar or any of its ingredients, and seek medical help for signs of a serious allergic reaction.

Bilypsa Tablet Storage and Disposal

• Keep Bilypsa tablets in their original packaging and store them in a cool, dry place away from direct heat, moisture and sunlight.
• Keep the medicine out of reach of children and pets to prevent accidental ingestion.
• Avoid storing the tablets in damp areas such as a bathroom unless the product packaging specifically allows it.
• Check the expiry date before use and do not take tablets that are expired, damaged or have changed in appearance.
• Do not flush unused tablets down the toilet or pour them into a sink unless local disposal guidance specifically recommends this.
• Ask a pharmacist about the appropriate way to dispose of unwanted or expired medicine in your area.

Bilypsa 4 mg Tablet contains saroglitazar and may be prescribed for diabetic dyslipidemia and related metabolic conditions, including selected patients with fatty liver. For current product information and Bilypsa 4mg Tablet price, AustraliaRXMeds provides available pack details and pricing.